ArticleWorld journal of microbiology & biotechnology2025
Zinc sulfate acts as an efflux pump inhibitor on Pseudomonas aeruginosa clinical isolates.
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Synergy Between the Auranofin Analogue PEtInternational journal of molecular sciences · 2026Article
- Anti-QS Strategies AgainstMicroorganisms · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Efflux pumps in Pseudomonas aeruginosa play an important role in decreasing the bacterium's antibiotic susceptibility. This study aimed to identify P. aeruginosa efflux pumps and examine the effect of Zinc sulfate on these pumps. This study was conducted on 104 P. aeruginosa clinical isolates collected from different types of specimens. The antimicrobial susceptibility pattern of all isolates was examined by disc diffusion and microdilution methods. A Cartwheel test was done for phenotypic detection of P. aeruginosa efflux pumps in the presence and absence of zinc sulfate. The expression of efflux pumps encoding genes and their regulators in the presence and absence of zinc sulfate was measured using real-time reverse transcriptase PCR. A high rate of multidrug-resistant (MDR) pattern was observed among the tested isolates (55.7%). Combining different antibiotics with Zinc sulfate exhibited synergistic effects against most of the studied isolates. The addition of sub-inhibitory concentrations of Zinc sulfate to the cartwheel test was found to inhibit efflux pump activity in all tested isolates. The expression of the positive regulator gene, mexT, was significantly decreased. Additionally, Zinc sulfate significantly upregulated the expression of the mexR gene (P-value < 0.05), a negative regulator of the MexAB-OprM efflux pump. Zinc sulfate demonstrated a strong antimicrobial effect against P. aeruginosa clinical isolates. We recommend the use of Zinc sulfate as an antibiotic adjuvant and efflux pump inhibitor in the treatment of P. aeruginosa infections to enhance the bacterium's susceptibility to antimicrobial agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.